Managed Care

 

Chronic disease cited as reason for increase in drug expenditures

MANAGED CARE August 2002. © MediMedia USA
Managed Care Outlook

Chronic disease cited as reason for increase in drug expenditures

MANAGED CARE August 2002. ©MediMedia USA










Retail prescription drug sales, in terms of dollars, rose 17.3 percent in 2001, though increases varied widely from state to state. An audit by Verispan Scott-Levin shows that increases in drug expenditures ranged from 12 percent in Maine to 25 percent in Alaska. Verispan Scott-Levin collects information from over 140 million prescription claims monthly, covering 71 percent of retail dispensing activity nationwide. Verispan is a new joint venture of Quintiles Transnational Corp. (which included Scott-Levin) and McKesson Corp.

Increase in expenditures, by state

SOURCE: VERISPAN SCOTT-LEVIN, SOURCE PRESCRIPTION AUDIT, 2001

Meetings

4th Partnering With ACOs Summit Los Angeles, CA October 27–28, 2014
PCMH & Shared Savings ACO Leadership Summit Nashville, TN November 3–4, 2014
2014 Annual HEDIS® and Star Ratings Symposium Nashville, TN November 3–4, 2014
Medicare Risk Adjustment, Revenue Management, & Star Ratings Fort Lauderdale, FL November 12–14, 2014
World Orphan Drug Congress Europe 2014 Brussels, Belgium November 12–14, 2014
Healthcare Chief Medical Officer Forum Alexandria, VA November 13–14, 2014
Home Care Leadership Summit Atlanta, GA November 17–18, 2014
HealthIMPACT Southeast Tampa, FL January 23, 2015